Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs geared toward growing the horizons of cytokine-based immunotherapy, specifically for cancers where cure selections remain limited. Utilize the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/deutsche-borse-expands-copyright-custody-via-clearstream/